193 related articles for article (PubMed ID: 33710416)
21. Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Toomey S; Gunther J; Carr A; Weksberg DC; Thomas V; Salvucci M; Bacon O; Sherif EM; Fay J; Kay EW; Sheehan KM; McNamara DA; Sanders KL; Mathew G; Breathnach OS; Grogan L; Morris PG; Foo WC; You YN; Prehn JH; O'Neill B; Krishnan S; Hennessy BT; Furney SJ
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640573
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of pathologic complete response for locally advanced rectal cancer.
Cloos AJ; Schissel M; Batra R; Donahue SR; Wenos CD; Kumar T; Leinicke JA; Thompson JS; Langenfeld SJ
Am J Surg; 2023 Dec; 226(6):873-877. PubMed ID: 37460372
[TBL] [Abstract][Full Text] [Related]
24. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
25. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
[TBL] [Abstract][Full Text] [Related]
26. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
Swellengrebel HA; Bosch SL; Cats A; Vincent AD; Dewit LG; Verwaal VJ; Nagtegaal ID; Marijnen CA
Radiother Oncol; 2014 Jul; 112(1):44-51. PubMed ID: 25018000
[TBL] [Abstract][Full Text] [Related]
27. A lower cut-off for lymph node harvest predicts for poorer overall survival after rectal surgery post neoadjuvant chemoradiotherapy.
Yeo CS; Syn N; Liu H; Fong SS
World J Surg Oncol; 2020 Mar; 18(1):58. PubMed ID: 32197615
[TBL] [Abstract][Full Text] [Related]
28. Predicting the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Soluble Immune Checkpoints.
Ari A; Sevik H; Sevinc MM; Tatar C; Buyukasik K; Surel AA; Idiz UO
Cancer Biother Radiopharm; 2024 Apr; 39(3):247-254. PubMed ID: 38010745
[No Abstract] [Full Text] [Related]
29. [Short-Term Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer].
Sakamoto Y; Kurebayashi H; Sakamoto S; Matsunaka T; Maegawa N; Shimada M; Tagai N; Sawai K; Morikawa M; Koneri K; Tamaki M; Murakami M; Hirono Y; Goi T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1762-1764. PubMed ID: 38303199
[TBL] [Abstract][Full Text] [Related]
30. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
[TBL] [Abstract][Full Text] [Related]
31. Evaluation Of Pathological Response And Its Predictors In Carcinoma Rectum Following Neoadjuvant Chemoradiation.
Nawaz S; Nayanar SK; Yahiya N
Gulf J Oncolog; 2021 Sep; 1(37):17-22. PubMed ID: 35152190
[TBL] [Abstract][Full Text] [Related]
32. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
33. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer.
Ren DL; Li J; Yu HC; Peng SY; Lin WD; Wang XL; Ghoorun RA; Luo YX
World J Gastroenterol; 2019 Jan; 25(1):118-137. PubMed ID: 30643363
[TBL] [Abstract][Full Text] [Related]
34. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.
Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822
[TBL] [Abstract][Full Text] [Related]
35. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
36. [The Local Control Effect of Surgical Treatment after Neoadjuvant Chemoradiotherapy for Rectal Adenocarcinoma with Inguinal Lymph Node Metastasis].
Ueta K; Yamashita K; Sumi Y; Kanemitsu K; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1443-1445. PubMed ID: 28133017
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.
Tokuhara K; Ueyama Y; Nakatani K; Yoshioka K; Kon M
World J Surg Oncol; 2016 Apr; 14():136. PubMed ID: 27129578
[TBL] [Abstract][Full Text] [Related]
38. Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elective surgery.
Heldens AF; Bongers BC; de Vos-Geelen J; van Meeteren NL; Lenssen AF
Eur J Surg Oncol; 2016 Sep; 42(9):1322-30. PubMed ID: 27156145
[TBL] [Abstract][Full Text] [Related]
39. The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy.
Shimada A; Matsuda T; Sawada R; Hasegawa H; Yamashita K; Harada H; Urakawa N; Goto H; Kanaji S; Oshikiri T; Kakeji Y
Sci Rep; 2023 Oct; 13(1):17111. PubMed ID: 37816855
[TBL] [Abstract][Full Text] [Related]
40. Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: An analysis from the National Cancer Data Base.
Sineshaw HM; Jemal A; Thomas CR; Mitin T
Cancer; 2016 Jul; 122(13):1996-2003. PubMed ID: 27074300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
